v3.25.1
Condensed Consolidated Statements of Stockholders’ Deficit - USD ($)
Total
Common stock
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2023   8,331,161      
Beginning balance at Dec. 31, 2023 $ (5,047,640) $ 833 $ 166,548,454 $ (360,896) $ (171,236,031)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 627,700   627,700    
Issuance of common stock, net of issuance costs (in shares)   50,664      
Issuance of common stock, net of issuance costs 215,113 $ 5 215,108    
Net loss (6,755,356)       (6,755,356)
Foreign currency translation adjustments (39,227)     (39,227)  
Ending balance (in shares) at Mar. 31, 2024   8,381,825      
Ending balance at Mar. 31, 2024 $ (10,999,410) $ 838 167,391,262 (400,123) (177,991,387)
Beginning balance (in shares) at Dec. 31, 2024 8,700,386 8,700,386      
Beginning balance at Dec. 31, 2024 $ (6,012,089) $ 870 169,705,480 (428,809) (175,289,630)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 377,357   377,357    
Issuance of common stock, net of issuance costs (in shares)   150,000      
Issuance of common stock, net of issuance costs 436,248 $ 15 436,233    
Net loss (4,378,307)       (4,378,307)
Foreign currency translation adjustments $ 13,090     13,090  
Ending balance (in shares) at Mar. 31, 2025 8,850,386 8,850,386      
Ending balance at Mar. 31, 2025 $ (9,563,701) $ 885 $ 170,519,070 $ (415,719) $ (179,667,937)